Outlook Therapeutics
OTLK----
Forecast & Rating4 analysts currently cover Outlook Therapeutics, of which 2 give a positive rating. The average price target is $5.50, about 291.5% upside from the current price of $1.41. Coverage is limited, so the data is for reference only. Data as of Jul 25, 2026; this does not constitute investment advice.
Jul 24, 2026Price forecast
$5.50291.46%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy0.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast baselineJul 19, 2026
Forecast met0.0%
Stock price$1.41
Average forecast price$5.5
Highest forecast price$10
Lowest forecast price$1
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.